Developmental exposure to the synthetic progestin, 17α-hydroxyprogesterone caproate, disrupts the mesocortical serotonin pathway and alters impulsive decision-making in rats.


Journal

Developmental neurobiology
ISSN: 1932-846X
Titre abrégé: Dev Neurobiol
Pays: United States
ID NLM: 101300215

Informations de publication

Date de publication:
09 2021
Historique:
revised: 20 07 2021
received: 14 04 2021
accepted: 23 07 2021
pubmed: 29 7 2021
medline: 1 4 2022
entrez: 28 7 2021
Statut: ppublish

Résumé

The synthetic progestin, 17α-hydroxyprogesterone caproate (17-OHPC), is administered to women at risk for preterm birth during a critical period of fetal development for mesocortical pathways. Yet, little information is available regarding the potential effects of 17-OHPC on the developing fetal brain. In rat models, the mesocortical serotonin pathway is sensitive to progestins. Progesterone receptor (PR) is expressed in layer 3 pyramidal neurons of medial prefrontal cortex (mPFC) and in serotonergic neurons of the dorsal raphe. The present study tested the hypothesis that exposure to 17-OHPC during development disrupts serotonergic innervation of the mPFC in adolescence and impairs behavior mediated by this pathway in adulthood. Administration of 17-OHPC from postnatal days 1-14 decreased the density of SERT-ir fibers within superficial and deep layers and decreased the density of synaptophysin-ir boutons in all layers of prelimbic mPFC at postnatal day 28. In addition, rats exposed to 17-OHPC during development were less likely to make impulsive choices in the Delay Discounting task, choosing the larger, delayed reward more often than controls at moderate delay times. Interestingly, 17-OHPC exposed rats were more likely to fail to make any choice (i.e., increased omissions) compared to controls at longer delays, suggesting disruptions in decision-making. These results suggest that further investigation is warranted in the clinical use of 17-OHPC to better inform a risk/benefit analysis of progestin use in pregnancy.

Identifiants

pubmed: 34318625
doi: 10.1002/dneu.22847
pmc: PMC8440456
mid: NIHMS1728250
doi:

Substances chimiques

Progestins 0
17 alpha-Hydroxyprogesterone Caproate 276F2O42F5
Serotonin 333DO1RDJY

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

763-773

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD093907
Pays : United States

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Biol Psychiatry. 2000 Mar 15;47(6):562-76
pubmed: 10715363
Microsc Res Tech. 1999 Jul 1;46(1):24-47
pubmed: 10402270
Neurosci Lett. 2002 Feb 22;319(3):157-61
pubmed: 11834317
Am J Perinatol. 2012 Oct;29(9):665-72
pubmed: 22773279
Behav Pharmacol. 1996 Aug;7(4):395-399
pubmed: 11224433
Ann N Y Acad Sci. 1990;600:297-313; discussion 314
pubmed: 2252317
Cereb Cortex. 2003 Mar;13(3):282-96
pubmed: 12571118
Cereb Cortex. 2009 Nov;19(11):2719-27
pubmed: 19293395
Pharmacol Biochem Behav. 2002 Apr;71(4):773-85
pubmed: 11888568
Science. 2001 Jun 29;292(5526):2499-501
pubmed: 11375482
Dev Neurobiol. 2008 Oct;68(12):1378-90
pubmed: 18712784
Neuropsychopharmacology. 2006 Feb;31(2):297-309
pubmed: 16012531
Semin Perinatol. 2017 Dec;41(8):461-467
pubmed: 28947068
Neuron. 2012 Dec 20;76(6):1057-70
pubmed: 23259943
Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80
pubmed: 12373437
J Comp Neurol. 1985 Nov 15;241(3):253-67
pubmed: 2418068
Neuropsychologia. 2015 Apr;70:206-13
pubmed: 25725416
Endocrine. 1999 Dec;11(3):257-67
pubmed: 10786822
Am J Obstet Gynecol. 2021 Feb;224(2):175-186
pubmed: 33035472
J Neurosci. 2006 Aug 23;26(34):8810-8
pubmed: 16928870
Ann Pharmacother. 2013 Apr;47(4):527-36
pubmed: 23535817
Endocrinology. 2016 Jan;157(1):77-82
pubmed: 26556535
Anat Rec. 2002 Jun 1;267(2):87-93
pubmed: 11997877
Neurosci Behav Physiol. 1993 May-Jun;23(3):271-6
pubmed: 8332246
J Neurosci. 1996 Nov 1;16(21):7021-9
pubmed: 8824338
Prog Brain Res. 2000;126:3-28
pubmed: 11105636
Neurobiol Learn Mem. 2008 May;89(4):567-73
pubmed: 18054257
Brain Res Dev Brain Res. 2005 Jun 30;157(2):124-31
pubmed: 15885807
Psychopharmacology (Berl). 2000 Apr;149(3):259-68
pubmed: 10823407
Cereb Cortex. 2006 Jan;16(1):106-14
pubmed: 15829733
Psychopharmacology (Berl). 2002 Mar;160(3):290-8
pubmed: 11889498
Am J Obstet Gynecol. 2020 Jul;223(1):B16-B18
pubmed: 32277894
J Neurosci. 2011 Jan 12;31(2):469-79
pubmed: 21228157
Neuroendocrinology. 2016;103(3-4):207-22
pubmed: 26065828
Neuroreport. 1998 Jun 1;9(8):1811-5
pubmed: 9665606
Mol Neurobiol. 2019 Feb;56(2):1405-1420
pubmed: 29948943
Neuroscience. 1980;5(2):207-27
pubmed: 6990293
Am J Perinatol. 2016 Feb;33(3):253-7
pubmed: 26788788
Eur J Neurosci. 2007 Oct;26(7):2066-73
pubmed: 17897403
Exp Neurol. 1982 Sep;77(3):654-67
pubmed: 7117469
J Neuroendocrinol. 2020 Jun;32(6):e12862
pubmed: 32485009
Early Hum Dev. 1991 Jul;26(1):61-7
pubmed: 1914989
Dev Cogn Neurosci. 2017 Aug;26:52-61
pubmed: 28521247
Am J Obstet Gynecol. 2015 Jul;213(1):16-22
pubmed: 25659469
Br J Pharmacol. 2011 Oct;164(4):1301-21
pubmed: 21410459
Gynecol Endocrinol. 2012 Nov;28(11):925-32
pubmed: 23057618
Brain Res. 1976 May 14;107(3):638-44
pubmed: 131603
Cereb Cortex. 2010 May;20(5):1046-52
pubmed: 19684244
Neuroendocrinology. 2011;94(1):84-8
pubmed: 21606641
Brain Res. 1986 Mar 26;369(1-2):285-97
pubmed: 3697744
Am J Obstet Gynecol. 2007 Dec;197(6):599.e1-7
pubmed: 18060946
J Neural Transm. 1981;50(1):13-27
pubmed: 7205246
Life Sci. 2010 Dec 18;87(23-26):738-42
pubmed: 21034751
Psychopharmacology (Berl). 1993;111(2):239-43
pubmed: 7870958
Am J Obstet Gynecol. 2014 Feb;210(2):131.e1-8
pubmed: 24036403
Behav Neurosci. 1998 Oct;112(5):1043-7
pubmed: 9829782
Neuroscience. 2012 Jul 26;215:42-58
pubmed: 22542672
Fertil Steril. 2003 Sep;80(3):554-9
pubmed: 12969697
J Neuroendocrinol. 2021 Mar;33(3):e12962
pubmed: 33719165
J Psychopharmacol. 2006 Jan;20(1):47-58
pubmed: 16204332
Neuropsychopharmacology. 1995 May;12(3):269-72
pubmed: 7612161
Mol Endocrinol. 2013 Apr;27(4):693-702
pubmed: 23487486
J Chem Neuroanat. 2013 Mar;48-49:29-45
pubmed: 23337940
Am J Obstet Gynecol. 2012 Nov;207(5):398.e1-8
pubmed: 22967833
Cereb Cortex. 2000 Oct;10(10):1014-27
pubmed: 11007552
Psychopharmacology (Berl). 2006 Nov;188(4):567-85
pubmed: 16670842
Psychopharmacology (Berl). 1999 Oct;146(4):400-12
pubmed: 10550490
Horm Behav. 2021 Jul 22;135:105039
pubmed: 34303952
Am J Obstet Gynecol. 2008 Aug;199(2):169.e1-5
pubmed: 18674659
Biol Neonate. 1973;23(1):95-108
pubmed: 4773522
Life Sci. 1983 Apr 25;32(17):2015-21
pubmed: 6188018
Front Neurosci. 2013 Apr 19;7:62
pubmed: 23626521
Am J Perinatol. 2020 Jan;37(2):127-136
pubmed: 31652479

Auteurs

Allyssa Fahrenkopf (A)

Psychogenics Inc., Paramus, New Jersey, USA.
Department of Psychology & Center for Neuroscience Research, University at Albany, Albany, New York, USA.

Grace Li (G)

Department of Integrative Anatomical Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.

Ruth I Wood (RI)

Department of Integrative Anatomical Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.

Christine K Wagner (CK)

Department of Psychology & Center for Neuroscience Research, University at Albany, Albany, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH